PUBLIC COMPANY
saveNEPHRON
USupdated 6mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Estuary flows out of stealth with $103M to propel kidney disease gene therapies into clinicEstuary Biotherapeutics has swum out of stealth with $103 million in funding to power a pair of gene therapies into clinical trials for an inherited kidney disorder.fiercebiotech · 1mo ago
- AAM sounds alarm on ‘unsustainable, race to the bottom’ for generics and biosimilarsAfter years of price pressures, the trade group argues “the economics of generics have deteriorated to the point where sustainability of the industry is in peril.”biospace · 2mo ago
comments(0)
5-min edit window · permanent after that